Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
Kværner AS, Harnæs H, Alavi DH, Bärebring L, Henriksen HB, Guren MG, Lauritzen PM, Eggesbø HB, Wiedswang G, Smeland S, Blomhoff R. Kværner AS, et al. Among authors: guren mg. Tidsskr Nor Laegeforen. 2020 May 19;140(8). doi: 10.4045/tidsskr.19.0769. Print 2020 May 26. Tidsskr Nor Laegeforen. 2020. PMID: 32463187 Free article. English, Norwegian.
Symptoms during chemotherapy in colorectal cancer patients.
Röhrl K, Guren MG, Småstuen MC, Rustøen T. Röhrl K, et al. Among authors: guren mg. Support Care Cancer. 2019 Aug;27(8):3007-3017. doi: 10.1007/s00520-018-4598-y. Epub 2019 Jan 3. Support Care Cancer. 2019. PMID: 30607676
[How do Norwegian oncologists perceive their working conditions?].
Marienhagen K, Helland A, Nordberg T, Guren MG, Hofsli E. Marienhagen K, et al. Among authors: guren mg. Tidsskr Nor Laegeforen. 2010 Mar 11;130(5):487-9. doi: 10.4045/tidsskr.08.0305. Tidsskr Nor Laegeforen. 2010. PMID: 20224615 Free article. Norwegian.
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
Bruun J, Kryeziu K, Eide PW, Moosavi SH, Eilertsen IA, Langerud J, Røsok B, Totland MZ, Brunsell TH, Pellinen T, Saarela J, Bergsland CH, Palmer HG, Brudvik KW, Guren T, Dienstmann R, Guren MG, Nesbakken A, Bjørnbeth BA, Sveen A, Lothe RA. Bruun J, et al. Among authors: guren mg, guren t. Clin Cancer Res. 2020 Aug 1;26(15):4107-4119. doi: 10.1158/1078-0432.CCR-19-3637. Epub 2020 Apr 16. Clin Cancer Res. 2020. PMID: 32299813
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer.
Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG. Slørdahl KS, et al. Among authors: guren mg. Acta Oncol. 2021 Jul;60(7):921-930. doi: 10.1080/0284186X.2021.1918763. Epub 2021 May 8. Acta Oncol. 2021. PMID: 33966592
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.
Smeby J, Kryeziu K, Berg KCG, Eilertsen IA, Eide PW, Johannessen B, Guren MG, Nesbakken A, Bruun J, Lothe RA, Sveen A. Smeby J, et al. Among authors: guren mg. EBioMedicine. 2020 Sep;59:102923. doi: 10.1016/j.ebiom.2020.102923. Epub 2020 Aug 13. EBioMedicine. 2020. PMID: 32799124 Free PMC article.
102 results